Global languages
2021-04-15
Non-regulatory

CellaVision presents the Interim report for the first quarter for 2021, on April 28, at 11:00 CET

CellaVision AB (publ) will publish the Interim report for the first quarter, on April 28, 2021 at 8:20 CET. The report will be available at www.cellavision.com

In connection with the release of the interim report analysts, investors and media are hereby invited to a telephone conference and audio webcast at 11:00 CET where Simon Østergaard, President & CEO, will present and comment the report.

The presentation will be in English via a conference call or audio webcast:
https://tv.streamfabriken.com/cellavision-q1-2021

Phone number for the conference:
SE: +46 8 50 558 375

UK: +44 33 33 009 268

US: +1 83 38 230 587

No pre-registration is required. Please dial in 5-10 minutes prior to the scheduled start time to facilitate a timely start.

Contact

Maria Morin
VP HR & Corporate Communications
Direct: +46 (0) 46 460 16 52
Mobile: +46 (0) 709 92 62 28

About Us

CellaVision is an innovative, global medical technology company that develops and sells its own leading systems for routine analysis of blood and other body fluids in health care services. The products replace manual laboratory work, and secure and support effective workflows and skills development within and between hospitals. The company has leading-edge expertise in sample preparation, image analysis, artificial intelligence and automated microscopy. Sales are via global partners with support from the parent company in Lund and by the company´s 18 local market support organizations covering more than 40 countries. In 2020, sales were SEK 471 million and the company's growth target is 15% per year over an economic cycle. CellaVision's registered office is in Lund, Sweden. The share is listed on the Nasdaq Stockholm, Mid Cap list. Read more at www.cellavision.com

Attachments

CellaVision presents the Interim report for the first quarter for 2021, on April 28, at 11:00 CET

Share